` HALO (Halozyme Therapeutics Inc) vs PNEXF (Pharnext SCA) Comparison - Alpha Spread

HALO
vs
PNEXF

Over the past 12 months, HALO has significantly outperformed PNEXF, delivering a return of +21% compared to the PNEXF's 0% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
HALO
PNEXF
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

HALO Intrinsic Value
LOCKED
Unlock
PNEXF Intrinsic Value
LOCKED
Unlock
Company Last Price Intrinsic Value DCF Value Multiples-Based Value Wall St Target
Halozyme Therapeutics Inc
NASDAQ:HALO
69.29 USD
Pharnext SCA
OTC:PNEXF
999 999.9999 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
HALO, PNEXF

HALO
PNEXF
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Halozyme Therapeutics Inc
Revenue
Pharnext SCA
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
HALO, PNEXF

HALO
PNEXF
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Halozyme Therapeutics Inc
NASDAQ:HALO
Pharnext SCA
OTC:PNEXF
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

HALO
83.6%
PNEXF
0%

Operating Margin

HALO
58.4%
PNEXF
-17 526.7%

Net Margin

HALO
22.7%
PNEXF
-21 040%

FCF Margin

HALO
25.5%
PNEXF
-15 953.3%

ROE

HALO
153.6%
PNEXF
114.6%

ROA

HALO
13.8%
PNEXF
-391.1%

ROIC

HALO
29%
PNEXF
3 092.9%

ROCE

HALO
38.2%
PNEXF
275.4%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
HALO, PNEXF

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
HALO, PNEXF

Performance Gap Between HALO and PNEXF
LOCKED
Unlock

Performance By Year
HALO, PNEXF

Loading
HALO
PNEXF
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare HALO to other stocks
ABBV
Abbvie Inc
More expensive
vs HALO
AMGN
Amgen Inc
More expensive
vs HALO
GILD
Gilead Sciences Inc
More expensive
vs HALO
EPE
Epizyme Inc
E
More expensive
vs HALO
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett